Multiple myeloma is a common hematologic malignancy among the elderly population.
Although there have been many advances in treatment over the past few decades, the …

Objective We investigated the prognostic value of 18 F-fluorodeoxyglucose positron
emission tomography/computed tomography (18 F-FDG PET/CT) in patients with multiple …

Purpose The parameter intensity of bone involvement (IBI) was recently proposed to
quantitatively assess patients with multiple myeloma using 18 F-fluorodeoxyglucose-PET …

Background Despite the significant upgrading in recent years of the role of 18 F-FDG
PET/CT in multiple myeloma (MM) diagnostics, there is a still unmet need for myeloma …

Prognostic Impact of Metabolic Heterogeneity in Patients Wit... : Clinical Nuclear Medicine
Prognostic Impact of Metabolic Heterogeneity in Patients With Newly Diagnosed Multiple …

The value of minimal residual disease (MRD) status by bone marrow and imaging analysis
as independent prognostic factors has been well established in multiple myeloma (MM) …

Simple Summary Multiple myeloma (MM) is associated with high morbidity and mortality and
variable survival that requires early identification of high-risk patients in order to quickly …

Serum markers and bone marrow examination are commonly used for monitoring therapy
response in multiple myeloma (MM), but this fails to identify minimal residual disease (MRD) …

Purpose The purpose of this study was to determine retrospectively, through a single-center
evaluation, whether FDG PET-CT normalized semi-quantitative parameters may predict …

Purpose To compare disease detection of myeloma using contemporary whole-body (WB)
MRI and fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT protocols and to correlate …